Recent Posts
61
C19 Notes Database / The Multiplicative Power of Masks
« Last post by stog on September 26, 2020, 05:24:11 PM »The Multiplicative Power of Masks
We now know that masks have an outsized effect on slowing the spread of COVID-19. And yet, some people oppose wearing masks because they view this as a personal choice rather than a public health issue. This misses the big picture because masks protect the wearer and the people around them. This two-way protection makes widespread mask-wearing a powerful way to extinguish an epidemic. on masks, we'll see how when 60% of people wear 60% effective masks, disease transmission drops by as much as 60% — roughly what's needed to stop the spread of COVID-19. –Aatish Bhatia
https://aatishb.com/maskmath/
We now know that masks have an outsized effect on slowing the spread of COVID-19. And yet, some people oppose wearing masks because they view this as a personal choice rather than a public health issue. This misses the big picture because masks protect the wearer and the people around them. This two-way protection makes widespread mask-wearing a powerful way to extinguish an epidemic. on masks, we'll see how when 60% of people wear 60% effective masks, disease transmission drops by as much as 60% — roughly what's needed to stop the spread of COVID-19. –Aatish Bhatia
https://aatishb.com/maskmath/
62
C19 Notes Database / 6 Months of Coronovirus a summary in Nature
« Last post by stog on July 10, 2020, 04:31:11 PM »6 Months of Coronovirus
Six months of coronavirus: the mysteries scientists are still racing to solve From immunity to the role of genetics, Nature looks at five pressing questions about COVID-19 that researchers are tackling.
Topics include
Why do people respond so differently?
What’s the nature of immunity and how long does it last?
Has the virus developed any worrying mutations?
How well will a vaccine work?
What is the origin of the virus?
https://www.nature.com/articles/d41586-020-01989-z
Six months of coronavirus: the mysteries scientists are still racing to solve From immunity to the role of genetics, Nature looks at five pressing questions about COVID-19 that researchers are tackling.
Topics include
Why do people respond so differently?
What’s the nature of immunity and how long does it last?
Has the virus developed any worrying mutations?
How well will a vaccine work?
What is the origin of the virus?
https://www.nature.com/articles/d41586-020-01989-z
63
C19 Notes Database / Re: How long does COVID-19 last
« Last post by stog on July 09, 2020, 09:34:50 AM »an email from the symptom study team today.
Their data suggest that only 52.2% of people recover within 13 days.
Their data suggest that only 52.2% of people recover within 13 days.
64
C19 Notes Database / Some positive social outcomes to the Pandemic
« Last post by stog on July 08, 2020, 03:54:21 PM »a super very readable pdf report i recommend which some of you might appreciate -- very positive and encouraging.
described by someone elsewhere as
"One of the most insightful, thoughtful, inspiring, (beautifully designed) analyses to come out of this terrible time. Humble in tone, profoundly important in content."
==
"In early March - when the spread of coronavirus gathered pace - we began to anticipate some of the possible social consequences of the pandemic and its likely effect on our relationships.
After three weeks of blogs and rapid consultation with our network of more than 300 organisations we established The Relationships Observatory.
Here we are gathering examples and insights and using what we learn to help sustain and develop the positives beyond the crisis."
http://relationshipsproject.org/reports/the-moment-we-noticed/
described by someone elsewhere as
"One of the most insightful, thoughtful, inspiring, (beautifully designed) analyses to come out of this terrible time. Humble in tone, profoundly important in content."
==
"In early March - when the spread of coronavirus gathered pace - we began to anticipate some of the possible social consequences of the pandemic and its likely effect on our relationships.
After three weeks of blogs and rapid consultation with our network of more than 300 organisations we established The Relationships Observatory.
Here we are gathering examples and insights and using what we learn to help sustain and develop the positives beyond the crisis."
http://relationshipsproject.org/reports/the-moment-we-noticed/
65
C19 Notes Database / Warning of serious brain disorders in people with mild coronavirus symptoms
« Last post by stog on July 08, 2020, 03:52:23 PM »UK neurologists publish details of mildly affected or recovering Covid-19 patients with serious or potentially fatal brain conditions
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned.
Neurologists are on Wednesday publishing details of more than 40 UK Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. In some cases, the neurological problem was the patient’s first and main symptom.
The cases, published in the journal Brain, revealed a rise in a life-threatening condition called acute disseminated encephalomyelitis (Adem), as the first wave of infections swept through Britain. At UCL’s Institute of Neurology, Adem cases rose from one a month before the pandemic to two or three per week in April and May. One woman, who was 59, died of the complication.
Read more A dozen patients had inflammation of the central nervous system, 10 had brain disease with delirium or psychosis, eight had strokes and a further eight had peripheral nerve problems, mostly diagnosed as Guillain-Barré syndrome, an immune reaction that attacks the nerves and causes paralysis. It is fatal in 5% of cases.
“We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses,” said Michael Zandi, a senior author on the study and a consultant at the institute and University College London Hospitals NHS foundation trust.
“What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease,” he added.
https://www.theguardian.com/world/2020/jul/08/warning-of-serious-brain-disorders-in-people-with-mild-covid-symptoms
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned.
Neurologists are on Wednesday publishing details of more than 40 UK Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. In some cases, the neurological problem was the patient’s first and main symptom.
The cases, published in the journal Brain, revealed a rise in a life-threatening condition called acute disseminated encephalomyelitis (Adem), as the first wave of infections swept through Britain. At UCL’s Institute of Neurology, Adem cases rose from one a month before the pandemic to two or three per week in April and May. One woman, who was 59, died of the complication.
Read more A dozen patients had inflammation of the central nervous system, 10 had brain disease with delirium or psychosis, eight had strokes and a further eight had peripheral nerve problems, mostly diagnosed as Guillain-Barré syndrome, an immune reaction that attacks the nerves and causes paralysis. It is fatal in 5% of cases.“We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses,” said Michael Zandi, a senior author on the study and a consultant at the institute and University College London Hospitals NHS foundation trust.
“What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease,” he added.
https://www.theguardian.com/world/2020/jul/08/warning-of-serious-brain-disorders-in-people-with-mild-covid-symptoms
66
C19 Notes Database / How long does COVID-19 last
« Last post by stog on July 06, 2020, 03:06:51 PM »How long does COVID-19 last?
Our data shows one in ten are sick for three weeks or more.
It’s commonly believed that COVID-19 is a short-term illness caused by infection with the novel SARS-CoV-2 coronavirus, and most health sources suggest that people will recover within two weeks or so.
But it’s becoming increasingly clear that this isn’t the case for everyone infected with coronavirus. Some people have reported symptoms for three weeks or more, while others have been suffering for months.
We look at what the data from the COVID Symptom Study app is telling us about the number of people living with COVID-19 over the longer term, the symptoms they are experiencing, and whether they are still infectious.
(The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.)
https://covid.joinzoe.com/post/covid-long-term?
Our data shows one in ten are sick for three weeks or more.
It’s commonly believed that COVID-19 is a short-term illness caused by infection with the novel SARS-CoV-2 coronavirus, and most health sources suggest that people will recover within two weeks or so.
But it’s becoming increasingly clear that this isn’t the case for everyone infected with coronavirus. Some people have reported symptoms for three weeks or more, while others have been suffering for months.
We look at what the data from the COVID Symptom Study app is telling us about the number of people living with COVID-19 over the longer term, the symptoms they are experiencing, and whether they are still infectious.
(The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.)
https://covid.joinzoe.com/post/covid-long-term?
67
C19 Notes Database / COVID-19 Symptom Study app
« Last post by stog on July 06, 2020, 03:01:53 PM »The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.
https://covid.joinzoe.com/data
https://covid.joinzoe.com/data
68
C19 Notes Database / pediatric multisystem inflammatory syndrome (MIS) may experience neurologic symp
« Last post by stog on July 04, 2020, 03:17:09 PM »Children with COVID-19-related pediatric multisystem inflammatory syndrome (MIS) may experience neurologic symptoms that involve the central nervous system and the peripheral nervous system, new research suggests.
In a case-series study of 27 children with COVID-19 MIS at a hospital in London, United Kingdom, four presented with new-onset symptoms that included headache, brainstem and cerebellar signs, encephalopathy, muscle weakness, and reduced reflexes.
After the patients were admitted to an intensive care unit, MRI scans showed splenium signal changes in all four patients. In addition, a "mild excess of slow activity" was found in the three children who underwent electroencephalography, and mild myopathic and neuropathic changes were found in the three who underwent nerve conduction measures and electromyography.
By end of study, all four showed neurologic improvement, and two had made a full recovery.
"Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19," write the investigators, led by Omar Abdel-Mannan, MD, Department of Neurology, Great Ormond Street Hospital for Children, London.
The findings were published online July 1 in JAMA Neurology.
https://www.medscape.com/viewarticle/933311
In a case-series study of 27 children with COVID-19 MIS at a hospital in London, United Kingdom, four presented with new-onset symptoms that included headache, brainstem and cerebellar signs, encephalopathy, muscle weakness, and reduced reflexes.
After the patients were admitted to an intensive care unit, MRI scans showed splenium signal changes in all four patients. In addition, a "mild excess of slow activity" was found in the three children who underwent electroencephalography, and mild myopathic and neuropathic changes were found in the three who underwent nerve conduction measures and electromyography.
By end of study, all four showed neurologic improvement, and two had made a full recovery.
"Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19," write the investigators, led by Omar Abdel-Mannan, MD, Department of Neurology, Great Ormond Street Hospital for Children, London.
The findings were published online July 1 in JAMA Neurology.
https://www.medscape.com/viewarticle/933311
69
C19 Notes Database / multisystem inflammatory syndrome in children (MIS-C)
« Last post by stog on July 04, 2020, 03:09:28 PM »July 2 2020
New data from active surveillance of the severe inflammatory condition associated with COVID-19 in previously healthy children provide further insight into the prevalence and course of the rare syndrome, but experts are concerned that current diagnostic criteria may not capture the true scope of the problem.
In separate reports published online June 29 in the New England Journal of Medicine, researchers from the New York State Department of Health and the Centers for Disease Control and Prevention (CDC) describe the epidemiology and clinical features of multisystem inflammatory syndrome in children (MIS-C) on the basis of information derived from targeted surveillance programs in New York State and across the country.
All children presented with fever or chills, and most had tachycardia (97%) and gastrointestinal symptoms (80%). Rash (60%), conjunctival injection (56%), hypotension (32%), and mucosal changes (27%) were reported. Among all of the children, levels of inflammatory markers were elevated, including levels of C-reactive protein (100%), d-dimer (91%), and troponin (71%). More than one third of the patients (36%) were diagnosed with myocarditis, and an additional 16% had clinical myocarditis.
Of the full cohort, 80% of the children required intensive care, 62% received vasopressor support, and two children died.
The high prevalence of cardiac dysfunction or depression, coagulopathy, gastrointestinal symptoms, mild respiratory symptoms, and indications for supplemental oxygen in patients with MIS-C stands in contrast to the clinical picture observed in most acute cases of COVID-19 in hospitalized children, the authors write.
"Although most children have mild or no illness from SARS-CoV-2 infection, MIS-C may follow Covid-19 or asymptomatic SARS-CoV-2 infection. Recognition of the syndrome and early identification of children with MIS-C, including early monitoring of blood pressure and electrocardiographic and echocardiographic evaluation, could inform appropriate supportive care and other potential therapeutic options," they continue.
https://www.medscape.com/viewarticle/933303
New data from active surveillance of the severe inflammatory condition associated with COVID-19 in previously healthy children provide further insight into the prevalence and course of the rare syndrome, but experts are concerned that current diagnostic criteria may not capture the true scope of the problem.
In separate reports published online June 29 in the New England Journal of Medicine, researchers from the New York State Department of Health and the Centers for Disease Control and Prevention (CDC) describe the epidemiology and clinical features of multisystem inflammatory syndrome in children (MIS-C) on the basis of information derived from targeted surveillance programs in New York State and across the country.
All children presented with fever or chills, and most had tachycardia (97%) and gastrointestinal symptoms (80%). Rash (60%), conjunctival injection (56%), hypotension (32%), and mucosal changes (27%) were reported. Among all of the children, levels of inflammatory markers were elevated, including levels of C-reactive protein (100%), d-dimer (91%), and troponin (71%). More than one third of the patients (36%) were diagnosed with myocarditis, and an additional 16% had clinical myocarditis.
Of the full cohort, 80% of the children required intensive care, 62% received vasopressor support, and two children died.
The high prevalence of cardiac dysfunction or depression, coagulopathy, gastrointestinal symptoms, mild respiratory symptoms, and indications for supplemental oxygen in patients with MIS-C stands in contrast to the clinical picture observed in most acute cases of COVID-19 in hospitalized children, the authors write.
"Although most children have mild or no illness from SARS-CoV-2 infection, MIS-C may follow Covid-19 or asymptomatic SARS-CoV-2 infection. Recognition of the syndrome and early identification of children with MIS-C, including early monitoring of blood pressure and electrocardiographic and echocardiographic evaluation, could inform appropriate supportive care and other potential therapeutic options," they continue.
https://www.medscape.com/viewarticle/933303
70
C19 Notes Database / Covid compliance checklist stickers on a pdf to add to records
« Last post by stog on July 02, 2020, 02:24:22 PM »some Covid compliance checklist stickers on a pdf
designed by an Osteopath to stick on Patient records, but could be adapted for use in other areas
COVID
Prescreening complete
No change since screening
Temp on arrival
Risks explained and understood PPEwornM A G V
Room cleaned before
Room cleaned after
No COVID symptoms during appt I have no symptoms/contact with
designed by an Osteopath to stick on Patient records, but could be adapted for use in other areas
COVID
Prescreening complete
No change since screening
Temp on arrival
Risks explained and understood PPEwornM A G V
Room cleaned before
Room cleaned after
No COVID symptoms during appt I have no symptoms/contact with